Please login to the form below

Not currently logged in
Email:
Password:

RedHill Biopharma

This page shows the latest RedHill Biopharma news and features for those working in and with pharma, biotech and healthcare.

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma has announced that its experimental sphingosine kinase-2 (SK2) opaganib demonstrated potent inhibition of SARS-CoV-2 in an in vitro clinical test. ... benefit COVID-19 patients by inhibiting the key drivers of disease progression -

Latest news

  • RedHill Biopharma advances phase 2/3 COVID-19 programme RedHill Biopharma advances phase 2/3 COVID-19 programme

    Submits clinical trial applications in Mexico and Brazil. Israeli biopharmaceutical company RedHill Biopharma has announced that it has accelerated its COVID-19 programme with the submission of new clinical trial applications ... Last month, RedHill

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios - Medical Animation

MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....